Paradigm Biocapital Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$11.5M Buy
2022
Q2
$8.96M Buy
2022
Q1
$5.37M Buy
2021
Q4
$4.2M Buy